Correlation Between Walker Dunlop and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Walker Dunlop and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Cadrenal Therapeutics,.
Diversification Opportunities for Walker Dunlop and Cadrenal Therapeutics,
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Walker and Cadrenal is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Walker Dunlop and Cadrenal Therapeutics,
Allowing for the 90-day total investment horizon Walker Dunlop is expected to under-perform the Cadrenal Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Walker Dunlop is 4.7 times less risky than Cadrenal Therapeutics,. The stock trades about -0.08 of its potential returns per unit of risk. The Cadrenal Therapeutics, Common is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 1,509 in Cadrenal Therapeutics, Common on August 27, 2024 and sell it today you would lose (10.00) from holding Cadrenal Therapeutics, Common or give up 0.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Walker Dunlop vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Walker Dunlop |
| Cadrenal Therapeutics, |
Walker Dunlop and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Walker Dunlop and Cadrenal Therapeutics,
The main advantage of trading using opposite Walker Dunlop and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| Walker Dunlop vs. Mr Cooper Group | Walker Dunlop vs. Velocity Financial Llc | Walker Dunlop vs. Security National Financial | Walker Dunlop vs. Encore Capital Group |
| Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. HCW Biologics | Cadrenal Therapeutics, vs. Scpharmaceuticals | Cadrenal Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |